glp-1 next generation Next-Generation Anti-Obesity Medicines GLP-1 agonists are part of

(Officially, less than 1% of checked luggage gets mishandled, but you dont want to be part of that 1%)

Formulated for enhanced absorption with SNAC

Though early, these studies spark excitement about Semaglutides potential in treating neurodegenerative disorders

FDA-Approved vs Research Compounds Understanding the distinction between FDA-approved peptides and research-only compounds is essential for evaluating safety: Category Examples Evidence Base Regulation FDA-Approved Semaglutide (Ozempic), Teriparatide (Forteo), Tesamorelin (Egrifta) Phase I-III clinical trials, post-market surveillance Prescription required, manufactured under cGMP Previously Approved Sermorelin (Geref withdrawn 2008) Clinical trial data exists, but product no longer marketed Research use only (currently) Research Only BPC-157, TB-500, Ipamorelin, KPV Preclinical data (varying depth), no completed human trials Sold for laboratory research, not human consumption For the complete list of FDA-approved peptides and their indications, see our FDA Approved Peptides List 2026 guide